Randomized trial of risk information formats in direct-to-consumer prescription drug advertisements

Medical Decision Making

Volumn 31, Issue 6, 2011, Pages

  Aikin, Kathryn J ^a   O'Donoghue, Amie C ^a   Swasy, John L ^b   Sullivan, Helen W ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b AMERICAN UNIVERSITY   (United States)

Author keywords

population based studies; randomized trial methodology; risk factor evaluation; scale development validation.

Indexed keywords

ADULT; ADVERTIZING; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUSTRY; FEMALE; HUMAN; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; UNITED STATES;

ADULT; ADVERTISING AS TOPIC; DRUG INDUSTRY; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; UNITED STATES;

EID: 80955142094     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X11413289     Document Type: Article

References (22)

1. 21 Code of Federal Regulations (CFR) Part 202.1(e)(3)(iii). Prescription Drug Advertising: Scope of Information to Be Included; Applicability to the Entire Advertisement. Washington, DC: Office of the Federal Register, National Archives and Records Administration; 2010. Available from: URL: http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=202.1
2. AikinKJSwasyJLBramanAC. Patient and Physician Attitudes and Behaviors Associated with DTC Promotion of Prescription Drugs: Summary of FDA Survey Research Results, Final Report, 2004. Available from: URL: http://www.fda.gov/ Drugs/ScienceResearch/ResearchAreas/ DrugMarketingAdvertisingandCommunicationsResearch/ucm151498.htm
3. Menon AM, Deshpande AD, Perri M, Zinkhan GM. Consumers' attention to the brief summary in print direct-to-consumer advertisements: perceived usefulness in patient-physician discussions. J Public Policy Marketing. 2003; 22: 181-91 (Pubitemid 38033531)
4. Thumma C. Consumer engagement with health information. Presented at the Marketing and Public Policy Conference; Washington, DC;.
5. Riggs DL, Holdsworth SM, McAvoy DR. Direct-to-consumer advertising: developing evidence-based policy to improve retention and comprehension. Health Aff. 2004; 23: 249-52
6. Stotka JL, Rotelli MD, Dowsett SA, et al. A new model for communicating risk information in direct-to-consumer print advertisements. Drug Inf J. 2007; 41: 111-27 (Pubitemid 46146065)
7. 21 Code of Federal Regulations (CFR) Parts 201, 314, and 601: Requirements on Content and Format of Labeling for Human Prescription Drug and Biological Products and Draft Guidances and Two Guidances for Industry on the Content and Format of Labeling for Human Prescription Drug and Biological Products; Final Rule and Notices. Washington, DC: Office of the Federal Register, National Archives and Records Administration; 2002. Available from: URL: http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/ LawsActsandRules/ucm084159.htm
8. Food and Drug Administration. Over-the-Counter Human Drugs; Labeling Requirements, 64 FR 13254. Washington, DC: Office of the Federal Register, National Archives and Records Administration; 1999. http://federalregister.gov/ a/99-6296. Accessed 26 November 2010.
9. Schwartz LM, Woloshin S, Welch HG. The drug facts box: providing consumers with simple tabular data on drug benefit and harm. Med Decis Making. 2007; 27: 655-62 (Pubitemid 47547602)
10. Schwartz LM, Woloshin S, Welch HG. Communicating drug benefits and harms with a drug facts box: two randomized trials. Ann Intern Med. 2009; 150: 516-27
11. Bandura A Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice Hall; 1986 :
12. Schwarzer R, Renner B. Social-cognitive predictors of health behavior: action self-efficacy and coping self-efficacy. Health Psychol. 2000; 19: 487-95
13. Strecher VJ, DeVellis BM, Becker MH, Rosenstock IM. The role of self-efficacy in achieving health behavior change. Health Educ Q. 1986; 13: 73-91
14. Cameron KA, Ross EL, Clayman ML, et al. Measuring patients' self-efficacy in understanding and using prescription medication. Patient Educ Couns. 2010; 80: 372-6
15. Levy AS, Fein SB, Schucker RE. More effective nutrition label formats are not necessarily more preferred. J Am Diet Assoc. 1992; 92: 1230-4
16. Washington, DC: Government Printing Office; 1995.
17. Baron RM, Kenny DA. The moderator-mediator distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986; 51: 1173-82
18. MacKinnon DP, Warsi G, Dwyer JH. A simulation study of mediated effect measures. Multivariate Behav Res. 1995; 30: 41-62
19. Weinstein ND. Misleading tests of health behavior theories. Ann Behav Med. 2007 ; 33: 1-10
20. Williams DM, Dunsinger BS. Suggestions for testing health behavior theories: implications for mediator analyses. Ann Behav Med. 2007; 34: 223 (Pubitemid 47535716)
21. Doak CC, Doak LG, Root JH Teaching Patients with Low Literacy Skills. 2 nd ed.Philadelphia: Lippincott; 1996. Philadelphia: Lippincott; 1996 :
22. Zajonc RB. Attitudinal effects of mere exposure. J Pers Soc Psychol Mon Suppl. 1968; 9 (2). 1-27